{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:03:30Z","timestamp":1784264610734,"version":"3.55.0"},"reference-count":32,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Bile duct tumor thrombus (BDTT) is a rare manifestation of hepatocellular carcinoma (HCC) that causes obstructive jaundice and is associated with a poor prognosis, although a treatment algorithm has yet to be established. We review the treatment landscape for HCC with BDTT, including surgical, transarterial, systemic, and radiotherapy options, and report, to our knowledge, the first case series of magnetic resonance-guided radiotherapy (MRgRT) for this condition. Four patients with unresectable HCC and BDTT were treated on a 0.35-T MR-linac with real-time cine-MRI gating (50 Gy in 5 fractions, n = 3; 40 Gy in 5 fractions, n = 1), with tumor response assessed by modified RECIST. All patients completed treatment without interruption. The best response was complete response in two patients and partial response in two, and obstructive jaundice resolved in both affected patients. The maximum radiation-attributed toxicity was a transient grade 3 bilirubin elevation that resolved without biliary intervention, and no treatment-related deaths occurred. Overall survival ranged from 5.5 to 29 months, with the two Child-Pugh class A patients without portal vein tumor thrombosis surviving 22 and 29 months. MRgRT for HCC with BDTT appears feasible with acceptable short-term safety and merits prospective evaluation.<\/jats:p>","DOI":"10.3390\/curroncol33070425","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:12:38Z","timestamp":1784257958000},"page":"425","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options"],"prefix":"10.3390","volume":"33","author":[{"given":"Nam Kyu","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Jung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun-Joo","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-5864","authenticated-orcid":false,"given":"Jung Hyun","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-8225","authenticated-orcid":false,"given":"Soon Kyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"},{"name":"The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-549X","authenticated-orcid":false,"given":"Myungsoo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3350\/cmh.2016.0088","article-title":"Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion","volume":"23","author":"An","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.21037\/atm-20-3935","article-title":"Comparison of different surgical interventions for hepatocellular carcinoma with bile duct tumor thrombus: A systematic review and meta-analysis","volume":"8","author":"Feng","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Conticchio, M., Maggialetti, N., Rescigno, M., Brunese, M.C., Vaschetti, R., Inchingolo, R., Calbi, R., Ferraro, V., Tedeschi, M., and Fantozzi, M.R. (2023). Hepatocellular carcinoma with bile duct tumor thrombus: A case report and literature review of 890 patients affected by uncommon primary liver tumor presentation. J. Clin. Med., 12.","DOI":"10.3390\/jcm12020423"},{"key":"ref_5","first-page":"349","article-title":"Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi","volume":"41","author":"Ueda","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"604971","DOI":"10.1155\/2014\/604971","article-title":"Clinical characteristics and surgical prognosis of hepatocellular carcinoma with bile duct invasion","volume":"2014","author":"Meng","year":"2014","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_7","first-page":"1","article-title":"Transarterial therapy for hepatocellular carcinoma invading the bile duct","volume":"9","author":"Miyayama","year":"2024","journal-title":"Interv. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"IMbrave150 Investigators. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lee, C.H., Chen, A.H., Hung, S.P., Hsieh, C.E., Tseng, J.H., Chen, P.J., Cheng, J.Y., Chang, J.T., Chan, K.M., and Lin, S.M. (2022). Proton beam therapy in managing unresectable hepatocellular carcinoma with bile duct invasion. Cancers, 14.","DOI":"10.3390\/cancers14071616"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Iizumi, T., Okumura, T., Hasegawa, N., Ishige, K., Fukuda, K., Seo, E., Makishima, H., Niitsu, H., Takahashi, M., and Sekino, Y. (2023). Proton beam therapy for hepatocellular carcinoma with bile duct invasion. BMC Gastroenterol., 23.","DOI":"10.1186\/s12876-023-02897-y"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Boldrini, L., Corradini, S., Gani, C., Henke, L., Hosni, A., Romano, A., and Dawson, L. (2021). MR-guided radiotherapy for liver malignancies. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.616027"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2014.11.028","article-title":"Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract","volume":"91","author":"Osmundson","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13014-025-02717-5","article-title":"Magnetic resonance imaging-guided radiotherapy for portal vein tumor thrombus in hepatocellular carcinoma: Outcomes and prognostic factors","volume":"20","author":"Lee","year":"2025","journal-title":"Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wu, J.Y., Huang, L.M., Bai, Y.N., Wu, J.Y., Wei, Y.G., Zhang, Z.B., and Yan, M.L. (2021). Imaging features of hepatocellular carcinoma with bile duct tumor thrombus: A multicenter study. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.723455"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00268-012-1845-0","article-title":"Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: A Korean multicenter study","volume":"37","author":"Moon","year":"2013","journal-title":"World J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1245\/s10434-021-10799-0","article-title":"Impact of bile duct tumor thrombus on the long-term surgical outcomes of hepatocellular carcinoma patients: A propensity score matching analysis","volume":"29","author":"Wu","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/SLA.0000000000003014","article-title":"Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: A Korea-Japan multicenter study","volume":"271","author":"Kim","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s11605-020-04813-1","article-title":"Thrombus-first surgery for hepatocellular carcinoma with bile duct tumor thrombus","volume":"25","author":"Sun","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Huang, L.M., Zeng, Z.X., Wu, J.Y., Li, Y.N., Wang, J.X., Fu, Y.K., Wu, J.Y., Wei, S.M., Lv, J.H., and Chen, W.Z. (2023). Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: A multicenter study. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1291479"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, Q., Chen, Y., Lin, K., Sun, C., Zheng, S., Chen, J., Wang, Y., Zhou, Y., Zhou, W., and Liu, J. (2021). Redefining hepatocellular carcinoma staging systems based on the bile duct invasion status: A multicenter study. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.673285"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00270-014-1032-9","article-title":"Transarterial chemoembolization for hepatocellular carcinomas with central bile duct invasion: Safety, prognosis, and predictive factors","volume":"38","author":"Choi","year":"2015","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000507051","article-title":"Efficacy and safety of sorafenib in unresectable hepatocellular carcinoma with bile duct invasion","volume":"98","author":"Tanaka","year":"2020","journal-title":"Oncology"},{"key":"ref_25","first-page":"EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Lau","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3892\/ol.2024.14465","article-title":"Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: A case report","volume":"28","author":"Ishihara","year":"2024","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3748\/wjg.v25.i20.2416","article-title":"Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma","volume":"25","author":"Choi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shannon, A.H., Manne, A., Diaz Pardo, D.A., and Pawlik, T.M. (2023). Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1193762"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3892\/ol.2025.15206","article-title":"Efficacy and safety of the immune checkpoint inhibitor-radiotherapy combination in advanced\/unresectable hepatocellular carcinoma: A systematic review and meta-analysis","volume":"30","author":"Cui","year":"2025","journal-title":"Oncol. Lett."},{"key":"ref_30","first-page":"114","article-title":"Effective relief of obstructive jaundice in a patient with nonresectable icteric-type hepatocellular carcinoma by external beam radiation therapy: Case report","volume":"24","author":"Sung","year":"2001","journal-title":"Chang Gung Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3904\/kjim.2011.26.1.94","article-title":"Successful treatment of stereotactic body radiation therapy combined with transarterial chemolipiodolization for hepatocellular carcinoma with biliary obstruction","volume":"26","author":"Park","year":"2011","journal-title":"Korean J. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13101","DOI":"10.3748\/wjg.v21.i46.13101","article-title":"Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma","volume":"21","author":"Kato","year":"2015","journal-title":"World J. Gastroenterol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/7\/425\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:05:58Z","timestamp":1784261158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/7\/425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["curroncol33070425"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33070425","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}